Elvitegravir
Elvitegravir
Elvitegravir (pronounced el-vi-teg-ra-vir) is an antiretroviral drug used in the treatment of HIV infection. It is a type of drug known as an integrase inhibitor, which works by blocking the action of an enzyme called integrase that the virus needs to replicate itself.
Etymology
The name "Elvitegravir" is derived from the words "Elvite" and "Integrase Inhibitor". "Elvite" is a prefix used in the naming of antiretroviral drugs, while "Integrase Inhibitor" refers to the class of drugs to which Elvitegravir belongs.
Usage
Elvitegravir is used in combination with other antiretroviral drugs to treat HIV infection. It is not a cure for HIV, but it can help to control the virus and prevent it from damaging the immune system.
Side Effects
Common side effects of Elvitegravir include nausea, diarrhea, and headache. More serious side effects can include liver problems and changes in the immune system.
Related Terms
- Antiretroviral therapy: The use of drugs to treat HIV infection.
- Integrase: An enzyme that HIV needs to replicate itself.
- Integrase inhibitor: A type of drug that blocks the action of integrase.
See Also
External links
- Medical encyclopedia article on Elvitegravir
- Wikipedia's article - Elvitegravir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski